Related Experiment Videos
Mitochondrial involvement in Alzheimer's disease
1Departments of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. eb19@colombia.edu
Biochimica Et Biophysica Acta
|March 17, 1999
Summary
The causes of Alzheimer's disease (AD) are unclear, but mitochondrial dysfunction may play a role. Reduced gene expression suggests lower neuronal activity impacts energy production in AD.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Neurodegenerative Diseases
Background:
- The etiology of neurodegenerative diseases like sporadic Alzheimer's disease (AD) is largely unknown.
- Mitochondrial dysfunction is increasingly implicated in AD pathogenesis, potentially causing energy deficits.
- Deafferentiation of neural circuits may lead to mitochondrial dysfunction and reduced neuronal activity.
Purpose of the Study:
- To investigate the role of mitochondrial dysfunction in Alzheimer's disease (AD) pathogenesis.
- To explore the relationship between reduced neuronal activity and energy deficits in AD.
- To examine the contribution of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) gene expression patterns.
Main Methods:
- Analysis of gene expression patterns for both mtDNA and nDNA encoded genes.
- Assessment of mitochondrial respiratory chain function in relation to neuronal activity.
- Review of evidence implicating mtDNA mutations in AD.
Main Results:
- Observed reduced expression of both mtDNA and nDNA encoded genes.
- Gene expression patterns suggest physiological down-regulation of the mitochondrial respiratory chain.
- This down-regulation correlates with reduced neuronal activity and potential energy deficit in AD.
Conclusions:
- Mitochondrial dysfunction, linked to reduced neuronal activity, is a potential contributor to Alzheimer's disease (AD) pathogenesis.
- The observed gene expression changes support a model of energy deficit due to down-regulated mitochondrial respiration.
- The specific role of somatic or inherited mtDNA mutations in AD-related mitochondrial dysfunction remains under investigation and is controversial.